These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33483212)

  • 1. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
    Brocato RL; Kwilas SA; Josleyn MD; Long S; Zeng X; Perley CC; Principe LM; Somerville B; Cohen MV; Hooper JW
    Vaccine; 2021 Feb; 39(7):1101-1110. PubMed ID: 33483212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection.
    Jay A; Kwilas SA; Josleyn M; Ricks K; Hooper JW
    PLoS One; 2023; 18(5):e0275082. PubMed ID: 37256884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
    Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE
    Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.
    Kamrud KI; Hooper JW; Elgh F; Schmaljohn CS
    Virology; 1999 Oct; 263(1):209-19. PubMed ID: 10544095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
    Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
    Hooper JW; Brocato RL; Kwilas SA; Hammerbeck CD; Josleyn MD; Royals M; Ballantyne J; Wu H; Jiao JA; Matsushita H; Sullivan EJ
    Sci Transl Med; 2014 Nov; 6(264):264ra162. PubMed ID: 25429055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study.
    Paulsen GC; Frenck R; Tomashek KM; Alarcon RM; Hensel E; Lowe A; Brocato RL; Kwilas SA; Josleyn MD; Hooper JW
    J Infect Dis; 2024 Jan; 229(1):30-38. PubMed ID: 37380156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial.
    Bavdekar A; Oswal J; Ramanan PV; Aundhkar C; Venugopal P; Kapse D; Miller T; McGray S; Zehrung D; Kulkarni PS;
    Vaccine; 2018 Feb; 36(9):1220-1226. PubMed ID: 29395526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.
    Geldenhuys HD; Mearns H; Foster J; Saxon E; Kagina B; Saganic L; Jarrahian C; Tameris MD; Dintwe OB; Van Rooyen M; Luabeya KK; Hussey G; Scriba TJ; Hatherill M; Zehrung D
    Vaccine; 2015 Sep; 33(37):4719-26. PubMed ID: 25862299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model.
    Imoto J; Konishi E
    Viral Immunol; 2005; 18(1):205-12. PubMed ID: 15802965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
    Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW
    Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.